$SERV
Serve Robotics Inc. /DE/

2023 Q1 Form 10-K Financial Statement

#000121390023025527 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue
YoY Change
Cost Of Revenue $367.3K $1.148M
YoY Change
Gross Profit -$327.0K -$1.041M
YoY Change
Gross Profit Margin
Selling, General & Admin $291.1K $576.8K
YoY Change -83.66%
% of Gross Profit
Research & Development $2.083M $13.57M
YoY Change 91.27%
% of Gross Profit
Depreciation & Amortization $465.6K $388.1K
YoY Change 813.91%
% of Gross Profit
Operating Expenses $3.900M $19.91M
YoY Change 87.46%
Operating Profit -$11.48K -$51.35K
YoY Change 45.56% -5.99%
Interest Expense $41.74K $636.3K
YoY Change -105.76%
% of Operating Profit
Other Income/Expense, Net -$910.9K -$902.1K
YoY Change
Pretax Income -$21.86M
YoY Change 0.88%
Income Tax
% Of Pretax Income
Net Earnings -$11.48K -$51.35K
YoY Change 45.56% -5.99%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 5.000M shares 5.000M shares 5.000M shares
Diluted Shares Outstanding 5.000M shares 5.000M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.716M
YoY Change -65.91%
Cash & Equivalents $12.37K $457.00
Short-Term Investments
Other Short-Term Assets $81.34K
YoY Change 628.85%
Inventory $618.3K $618.3K
Prepaid Expenses $81.34K
Receivables $23.70K $23.70K
Other Receivables $0.00
Total Short-Term Assets $12.37K $457.00 $3.439M
YoY Change 68.63% -59.26%
LONG-TERM ASSETS
Property, Plant & Equipment $3.376M $4.592M
YoY Change 3739.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $512.7K
YoY Change 430.43%
Total Long-Term Assets $0.00 $0.00 $5.105M
YoY Change 2260.61%
TOTAL ASSETS
Total Short-Term Assets $12.37K $457.00 $3.439M
Total Long-Term Assets $0.00 $0.00 $5.105M
Total Assets $12.37K $457.00 $8.544M
YoY Change 68.63% -1.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.89K $10.00K $162.0K
YoY Change 33.33% -51.82%
Accrued Expenses $37.43K $520.6K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $3.214M
YoY Change
Total Short-Term Liabilities $147.4K $124.0K $3.897M
YoY Change 71.13% 1058.75%
LONG-TERM LIABILITIES
Long-Term Debt $3.078M
YoY Change
Other Long-Term Liabilities $14.02M
YoY Change
Total Long-Term Liabilities $17.10M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $147.4K $124.0K $3.897M
Total Long-Term Liabilities $17.10M
Total Liabilities $147.4K $124.0K $21.00M
YoY Change 71.13% 6143.11%
SHAREHOLDERS EQUITY
Retained Earnings -$135.5K -$124.0K
YoY Change 70.65%
Common Stock $500.00 $500.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$135.0K -$123.5K -$12.45M
YoY Change
Total Liabilities & Shareholders Equity $12.37K $457.00 $8.544M
YoY Change 68.63% -1.3%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$11.48K -$51.35K
YoY Change 45.56% -5.99%
Depreciation, Depletion And Amortization $465.6K $388.1K
YoY Change 813.91%
Cash From Operating Activities -$5.591K -$48.85K
YoY Change -40.45% -5.37%
INVESTING ACTIVITIES
Capital Expenditures $3.645M
YoY Change 2148.72%
Acquisitions
YoY Change
Other Investing Activities -$416.0K
YoY Change 330.43%
Cash From Investing Activities -$4.061M
YoY Change 1469.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $17.50K $49.04K
YoY Change 75.35% 15.5%
NET CHANGE
Cash From Operating Activities -$5.591K -$48.85K
Cash From Investing Activities -$4.061M
Cash From Financing Activities $17.50K $49.04K
Net Change In Cash $11.91K $186.00
YoY Change 1911.66% -102.03%
FREE CASH FLOW
Cash From Operating Activities -$5.591K -$48.85K
Capital Expenditures $3.645M
Free Cash Flow -$5.591K -$3.694M
YoY Change 1628.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-56237
CY2022 dei Entity Registrant Name
EntityRegistrantName
Patricia Acquisition Corp.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3844872
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
2255 Glades Road
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 324A
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33431
CY2022 dei City Area Code
CityAreaCode
(561)
CY2022 dei Local Phone Number
LocalPhoneNumber
989-2208
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5000000 shares
CY2022 dei Auditor Name
AuditorName
Raich Ende Malter & Co. LLP
CY2022 dei Auditor Firm
AuditorFirmId
50
CY2022 dei Auditor Location
AuditorLocation
Melville, New York
CY2022Q4 us-gaap Cash
Cash
457 usd
CY2021Q4 us-gaap Cash
Cash
271 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
457 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
271 usd
CY2022Q4 us-gaap Assets
Assets
457 usd
CY2021Q4 us-gaap Assets
Assets
271 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7500 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
114000 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
64960 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
124000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
72460 usd
CY2022Q4 us-gaap Liabilities
Liabilities
124000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
72460 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5000000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
500 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
500 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124043 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72689 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-123543 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-72189 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
457 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
271 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51354 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54627 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-51354 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-54627 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-51354 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-54627 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000000 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-17562 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-54627 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-72189 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-51354 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-123543 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-51354 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-54627 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2500 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48854 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51627 usd
CY2022 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
49040 usd
CY2021 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
42460 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49040 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
42460 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
186 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9167 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
271 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9438 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
457 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
271 usd
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1. <span style="text-decoration:underline">Nature of Operations</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patricia Acquisition Corp. (the “Company”) was incorporated in the State of Delaware on November 9, 2020. The Company’s management has chosen December 31st for its fiscal year end.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly traded corporation. The Company’s principal business objective is to achieve long-term growth potential through a combination with a business, rather than immediate short-term earnings. The Company will not restrict its potential target companies to any specific business, industry, or geographical location. The analysis of business opportunities will be undertaken by, or under the supervision of, the officer and directors of the Company.</p>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022 patr Smaller Reporting Company Description
SmallerReportingCompanyDescription
(1) the market value of the ordinary shares held by non-affiliates equals or exceeds $250 million as of the prior June 30, and (2) the annual revenues equaled or exceeded $100 million during such completed fiscal year or the market value of the ordinary shares held by non-affiliates equals or exceeds $700 million as of the prior June 30.
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22300 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
11500 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
106000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
54600 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21 pure
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.18 pure
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
114000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
64960 usd
CY2022 patr Going Concern
GoingConcern
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 6. <span style="text-decoration:underline">Going Concern</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has incurred losses from inception of $124,043, has negative working capital of $123,543, and has a stockholders’ deficit of $123,543 as of December 31, 2022. Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the date these financial statements are issued. Management intends to finance operations over the next twelve months through additional borrowings on the existing Note.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.</p>
CY2022 us-gaap Stockholders Equity Other
StockholdersEquityOther
124043 usd
CY2022Q4 patr Working Capital Deficit
WorkingCapitalDeficit
123543 usd
CY2022 patr Net Income Loss Attributable To Parent
NetIncomeLossAttributableToParent
123543 usd
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001832483

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001213900-23-025527-index-headers.html Edgar Link pending
0001213900-23-025527-index.html Edgar Link pending
0001213900-23-025527.txt Edgar Link pending
0001213900-23-025527-xbrl.zip Edgar Link pending
f10k2022ex31-1_patriciaacq.htm Edgar Link pending
f10k2022ex32-1_patriciaacq.htm Edgar Link pending
f10k2022_patriciaacq.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
patr-20221231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
patr-20221231_cal.xml Edgar Link unprocessable
patr-20221231_def.xml Edgar Link unprocessable
patr-20221231_lab.xml Edgar Link unprocessable
patr-20221231_pre.xml Edgar Link unprocessable
f10k2022_patriciaacq_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending